Medisafe

Company Overview

Snapshot

Founded in August 2012 by Omri 'Bob' Shor, Rotem Shor, and Dudi Klein, Medisafe operates with 51–200 employees. The company has raised $51.5M across 7 funding rounds from 17 investors.

Business overview

Medisafe provides a personalized medication management platform designed to help patients adhere to their medication regimens. The platform connects users with family support, offers custom notifications for appointments and refills, medication updates, and personalized health recommendations. It also tracks progress by correlating medication adherence with health measurements like blood pressure and glucose levels. Medisafe serves patients, providers, and payers, aiming to improve patient satisfaction, quality of care, and reduce hospital admissions by addressing root causes of medication non-adherence. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Patient Engagement.

Strategic signal

In July 2026, Medisafe partnered with AssistRx to enhance patient engagement through smarter, more connected solutions. This collaboration signals a strategic move to integrate Medisafe's medication management capabilities with broader patient support services, indicating a focus on expanding its ecosystem and delivering more comprehensive digital health solutions to the market.

Company Intelligence Q&A

What is Medisafe's core business model?

Medisafe operates with B2C, B2B, and B2B2C business models, providing its medication management platform to individual patients, healthcare providers, and through partnerships with other businesses.

What was a significant partnership for Medisafe in 2026?

In July 2026, Medisafe united with AssistRx to power smarter, more connected patient engagement solutions.

When did Medisafe launch its digital document exchange?

In February 2022, Medisafe launched a digital document exchange to accelerate medication approvals.